Please provide your email address to receive an email when new articles are posted on . “This persistent hypoesthesia suggests permanent nerve and ganglion damage,” said Denise de Freitas, MD, from ...

March 4, 2010 — Patients with herpes zoster ophthalmicus (HZO) appear to have an increased risk of developing stroke, according to new research appearing online in the March 3 issue of Neurology. In a ...

Our group at Wills Eye Institute retrospectively reviewed the charts of all patients with a diagnosis of herpes zoster ophthalmicus (HZO) who were seen in 2008. Whereas some of these patients were ...

In adults aged 50 years or older, the 2-dose recombinant zoster vaccine is linked to reduced risk for HZO, acute myocardial infarction, and stroke. HealthDay News — Two doses of recombinant zoster ...

A 9-year-old girl of Indian origin presented with a vesicular eruption over the left ophthalmic division of the trigeminal nerve with no involvement of the nasal tip (Figure 1). A diagnosis of HZO was ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Valacyclovir can be beneficial for treating multiple episodes of keratitis or iritis in patients with ...

A 56-year-old woman who was otherwise healthy presented with a one-week history of right eye pain, headache and a rash on her forehead. On physical examination, she had a temperature of 38°C and a ...

The varicella-zoster virus is responsible for about 1 million new shingles cases in the U.S. each year—and shingles vision side effects occur in about 80,000 of them. Despite the relative rarity of ...

The global herpes zoster ophthalmicus market size is anticipated to increase steadily from 2022 to 2032, at a CAGR of 2.9%. In 2022 and 2032, it is projected to be worth US$ 4.7 billion and US$ 8.2 ...

"These data suggest that health benefits of RZV immunization may extend beyond the well-described prevention of herpes zoster and postherpetic neuralgia." HealthDay News — Two doses of recombinant ...

We read with interest the article by Drew et al, 1 and would like to comment on the authors’ clinical management and conclusions. The authors mentioned that this patient received acyclovir and ...